You are here

lampalizumab

Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII

Endpoints

Sat, 09/9/17 - 02:14 pm

5 Reasons Roche Thinks It Can Outclass the Competition

Motley Fool

Fri, 11/13/15 - 04:23 pm

dry macular degeneration

Roche to show investors strength in and beyond cancer drugs

Yahoo/Reuters

Tue, 10/1/13 - 08:41 am

antibody conjugates

Roche looks to replicate cancer success with eye drugs

Reuters

Tue, 08/27/13 - 05:40 pm